After beating estimates last quarter by $0.08, Robbins & Myers (NYS: RBN) has set the standard for itself. The company will unveil its latest earnings on Tuesday. Robbins & Myers is a supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical, and pharmaceutical markets.
What analysts say:
Buy, sell, or hold?: Analysts strongly back Robbins & Myers, with seven of nine rating it a buy and the remainder rating it a hold. Analysts like Robbins & Myers better than competitor Colfax overall. Analysts haven't adjusted their rating of Robbins & Myers for the past three months.
Revenue forecasts: On average, analysts predict $237.9 million in revenue this quarter. That would represent a rise of 10.7% from the year-ago quarter.
Wall Street earnings expectations: The average analyst estimate is earnings of $0.74 per share. Estimates range from $0.70 to $0.76.
What our community says:
CAPS All-Stars are solidly behind the stock, with 96.4% granting it an outperform rating. The community at large agrees with the All-Stars, with 95.5% assigning it a rating of outperform. Despite the majority sentiment in favor of Robbins & Myers, the stock has a middling CAPS rating of three out of five stars.
Robbins & Myers' profit has risen year-over-year by an average of more than fourfold over the past five quarters. The company boosted its gross margin by 2.3 percentage points in the last quarter. Revenue rose 44.8% while cost of sales rose 39.3% to $141.8 million from a year earlier.
Now, a look at how efficient management has been at running the business. Traditionally, margins serve as an illustration of how efficiently a company captures portions of sales dollars. Robbins & Myers has seen increasing operating margins year-over-year for the last four quarters. Operating margins reflect the total sales revenue that the company retains after costs. Here is how Robbins & Myers has been doing for the last four quarters:
For all our Robbins & Myers-specific analysis, including earnings and beyond, add Robbins & Myers to My Watchlist.
The Motley Fool has a disclosure policy.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Earnings estimates provided by Zacks.
At the time thisarticle was published
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.